This $1,616,282 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Weill Medical College of Cornell University on "Targeting Inflammatory Pathways in Breast Cancer Brain Metastases for the Treatment of Edema and Radiation Necrosis Using Anti-VEGF Ultrasmall Particle Therapy." The research aims to develop novel treatment approaches for addressing the complications of brain metastases from breast cancer, including edema and radiation necrosis. The award will fund a 2-year research project focusing on preclinical studies and translational research to advance this innovative therapeutic strategy. As a leading academic medical center, Weill Medical College has a strong track record of securing federal grants to conduct cutting-edge biomedical research and clinical studies that address critical healthcare challenges, including for military service members and veterans.
Generated 3/4/25, 7:06 AM